Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. STKE, 2 January 2007
Vol. 2007, Issue 367, p. re1
[DOI: 10.1126/stke.3672007re1]
REVIEWS
How Do MicroRNAs Regulate Gene Expression?
Richard J. Jackson* and
Nancy Standart*
Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK.
Abstract:
Several thousand human genes, amounting to about one-third of the whole genome, are potential targets for regulation by the several hundred microRNAs (miRNAs) encoded in the genome. The regulation occurs posttranscriptionally and involves the ~21-nucleotide miRNA interacting with a target site in the mRNA that generally has imperfect complementarity to the miRNA. The target sites are almost invariably in the 3'-untranslated region of the messenger RNA (mRNA), often in multiple copies. Metazoan miRNAs were previously thought to down-regulate protein expression by inhibiting target mRNA translation at some stage after the translation initiation step, without much effect on mRNA abundance. However, recent studies have questioned these suppositions. With some targets, an increase in the rate of mRNA degradation by the normal decay pathway contributes to the decrease in protein expression. miRNAs can also inhibit translation initiation, specifically the function of the cap-binding initiation factor, eIF4E. Repressed target mRNAs as well as miRNAs themselves accumulate in cytoplasmic foci known as P-bodies, where many enzymes involved in mRNA degradation are concentrated. However, P-bodies may also serve as repositories for the temporary and reversible storage of untranslated mRNA, and reducing the expression (knockdown) of several distinct P-body protein components can alleviate miRNA-mediated repression of gene expression.
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Nancy R. Gough (8 July 2008) Sci. Signal.1 (27), ec244.
[DOI: 10.1126/scisignal.127ec244] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Liver-Specific MicroRNA miR-122 Enhances the Replication of Hepatitis C Virus in Nonhepatic Cells.
J. Chang, J.-T. Guo, D. Jiang, H. Guo, J. M. Taylor, and T. M. Block (2008)
J. Virol.
82, 8215-8223
|Abstract »|Full Text »|PDF »
Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies.
J. N. Savas, A. Makusky, S. Ottosen, D. Baillat, F. Then, D. Krainc, R. Shiekhattar, S. P. Markey, and N. Tanese (2008)
PNAS
105, 10820-10825
|Abstract »|Full Text »|PDF »
Computational analysis of miRNA-mediated repression of translation: Implications for models of translation initiation inhibition.
Neutrophil-selective CD18 silencing using RNA interference in vivo.
X. Cullere, M. Lauterbach, N. Tsuboi, and T. N. Mayadas (2008)
Blood
111, 3591-3598
|Abstract »|Full Text »|PDF »
MicroRNAs as Prognostic Indicators and Therapeutic Targets: Potential Effect on Breast Cancer Management.
A. J. Lowery, N. Miller, R. E. McNeill, and M. J. Kerin (2008)
Clin. Cancer Res.
14, 360-365
|Abstract »|Full Text »|PDF »
Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells.
L. B. Frankel, N. R. Christoffersen, A. Jacobsen, M. Lindow, A. Krogh, and A. H. Lund (2008)
J. Biol. Chem.
283, 1026-1033
|Abstract »|Full Text »|PDF »
3' Terminal oligo U-tract-mediated stimulation of decapping.
Target-specific requirements for enhancers of decapping in miRNA-mediated gene silencing.
A. Eulalio, J. Rehwinkel, M. Stricker, E. Huntzinger, S.-F. Yang, T. Doerks, S. Dorner, P. Bork, M. Boutros, and E. Izaurralde (2007)
Genes & Dev.
21, 2558-2570
|Abstract »|Full Text »|PDF »
MicroRNA Inhibition of Translation Initiation in Vitro by Targeting the Cap-Binding Complex eIF4F.
G. Mathonnet, M. R. Fabian, Y. V. Svitkin, A. Parsyan, L. Huck, T. Murata, S. Biffo, W. C. Merrick, E. Darzynkiewicz, R. S. Pillai, et al. (2007)
Science
317, 1764-1767
|Abstract »|Full Text »|PDF »
Isolation of microRNA targets by miRNP immunopurification.
The role of GW/P-bodies in RNA processing and silencing.
A. Jakymiw, K. M. Pauley, S. Li, K. Ikeda, S. Lian, T. Eystathioy, M. Satoh, M. J. Fritzler, and E. K. L. Chan (2007)
J. Cell Sci.
120, 1317-1323
|Abstract »|Full Text »|PDF »